Skip to main content

ADVERTISEMENT

Lymphoma

Michael Wang, MD, Talks LOXO-305 for MCL, WM
Videos
12/07/2020
In this video, Dr Wang discusses the use of LOXO-305, a highly selective BTK inhibitor, in patients with pretreated MCL, WM, and other NHLs.
In this video, Dr Wang discusses the use of LOXO-305, a highly selective BTK inhibitor, in patients with pretreated MCL, WM, and other NHLs.
In this video, Dr Wang discusses...
12/07/2020
Oncology
Dr Cook Talks Advancements in the Treatment of FL With EZH2 Inhibitors
Videos
11/01/2020
Perry C. Cook, MD, talks about progress made in the use of EZH2 inhibitors for the treatment of patients with FL.
Perry C. Cook, MD, talks about progress made in the use of EZH2 inhibitors for the treatment of patients with FL.
Perry C. Cook, MD, talks about...
11/01/2020
Oncology
Tazemetostat Therapy for Patients With Relapsed/Refractory FL
Videos
10/28/2020
Perry C. Cook, MD, discusses the use of tazemetostat for the treatment of patients with relapsed/refractory FL.
Perry C. Cook, MD, discusses the use of tazemetostat for the treatment of patients with relapsed/refractory FL.
Perry C. Cook, MD, discusses the...
10/28/2020
Oncology
Autologous Hematopoietic Stem Cell Transplant Safe, Effective for HIV-Related Lymphoma
Conference Insider
09/19/2020
Data presented at the virtual ESMO Congress support the use of ASCT in patients with HIV-related lymphoma.
Data presented at the virtual ESMO Congress support the use of ASCT in patients with HIV-related lymphoma.
Data presented at the virtual...
09/19/2020
Oncology
Key Updates on Brentuximab Vedotin for Classical Hodgkin Lymphoma
Debates and Roundtables
01/21/2020
Experts sat down with Oncology Learning Network to discuss key updates on the use of brentuximab vedotin in patients with classical Hodgkin lymphoma.
Experts sat down with Oncology Learning Network to discuss key updates on the use of brentuximab vedotin in patients with classical Hodgkin lymphoma.
Experts sat down with Oncology...
01/21/2020
Oncology
Differences in Biology and Treatment of FL and MZL
Videos
01/20/2020
Thomas Habermann, MD, explains differences in the treatment approaches for follicular and marginal zone lymphomas.
Thomas Habermann, MD, explains differences in the treatment approaches for follicular and marginal zone lymphomas.
Thomas Habermann, MD, explains...
01/20/2020
Oncology
Updates in Diagnosing and Treating Peripheral T-Cell Lymphoma
Videos
01/17/2020
Jia Ruan, MD, PhD, Weill Cornell Medicine, shares updates on the diagnosis and treatment of peripheral T-cell lymphoma.
Jia Ruan, MD, PhD, Weill Cornell Medicine, shares updates on the diagnosis and treatment of peripheral T-cell lymphoma.
Jia Ruan, MD, PhD, Weill Cornell...
01/17/2020
Oncology
Obinutuzumab Plus Lenalidomide Effective for High Tumor Burden FL
Videos
01/17/2020
Loretta Nastoupil, MD, discusses results from a study exploring obinutuzumab therapy plus lenalidomide in patients with untreated, high tumor burden FL.
Loretta Nastoupil, MD, discusses results from a study exploring obinutuzumab therapy plus lenalidomide in patients with untreated, high tumor burden FL.
Loretta Nastoupil, MD, discusses...
01/17/2020
Oncology
The Role of Observation in Follicular Lymphoma
Videos
01/06/2020
Carla Casulo, MD, University of Rochester Medical Center, discusses the role of observation in the treatment landscape of follicular lymphoma.
Carla Casulo, MD, University of Rochester Medical Center, discusses the role of observation in the treatment landscape of follicular lymphoma.
Carla Casulo, MD, University of...
01/06/2020
Oncology
Treatment Options for Advanced Stage Lymphoma
Videos
01/03/2020
Joseph Connors, MD, discusses the best choices for treating patients with advanced stage lymphoma.
Joseph Connors, MD, discusses the best choices for treating patients with advanced stage lymphoma.
Joseph Connors, MD, discusses...
01/03/2020
Oncology